Management of brain arteriovenous malformations

Current Opinion in Anaesthesiology

Volumn 18, Issue 5, 2005, Pages 484-489

  Lee, Chanhung Z ^a   Young, William L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arteriovenous malformation rupture; Brain arteriovenous malformation; Intracranial hemorrhage; Treatment options; Unruptured arteriovenous malformation

Indexed keywords

TETRACYCLINE DERIVATIVE;

AGE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BRAIN PROTECTION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENDOVASCULAR SURGERY; HEREDITY; HUMAN; INDUCED HYPOTHERMIA; MICROSURGERY; PRIORITY JOURNAL; RADIOSURGERY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; WARMING;

EID: 26244441521     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000182568.47927.f5     Document Type: Review

References (48)

1. Arteriovenous Malformation Study Group. Current concepts: arteriovenous malformations of the brain in adults. N Engl J Med 1999; 340:1812-1818.
2. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 2001; 124:1900-1926.
3. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet 2002; 359:863-873.
4. Halim AX, Johnston SC, Singh V, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 2004; 35:1697-1702.
5. Stapf C, Khaw AV, Sciacca RR, et al. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke 2003; 34:2664-2669.
6. Marks MP, Lane B, Steinberg GK, et al. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology 1990; 176:807-813.
7. Redekop G, TerBrugge K, Montanera W, et al. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg 1998; 89:539-546.
8. Meisel HJ, Mansmann U, Alvarez H, et al. Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery 2000; 46:793-800; discussion 800-802.
9. Kim EJ, Halim AX, Dowd CF, et al. The relationship of coexisting extranidal aneurysms to intracranial hemorrhage in patients harboring brain arteriovenous malformations. Neurosurgery 2004; 54:1349-1357; discussion 1357-1358. This study involving the relationship of co-existing extranidal aneurysms to intracranial hemorrhage in patients harboring brain AVMs highlighted the need for the additional risk-to-benefits analysis based on the distinction between aneurysm-associated and AVM-associated bleeding.
10. Ogilvy CS, Stieg PE, Awad I, et al. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the stroke council, American Stroke Association. Circulation 2001; 103:2644-2657.
11. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986; 65:476-483.
12. Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery 1994; 34:2-6; discussion 6-7.
13. Hartmann A, Stapf C, Hofmeister C, et al. Determinants of neurological outcome after surgery for brain arteriovenous malformation. Stroke 2000; 31:2361-2364.
14. Lawton MT, Du R, Tran M, et al. Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery 2005; 56:485-493. This study raised the alarm that the risk associated with the elective resection of unruptured AVMs might be higher than previously recognized.
15. Yu SC, Chan MS, Lam JM, et al. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. Am J Neuroradiol 2004; 25:1139-1143.
16. Oran I, Parildar M, Derbent A. Ventricular/paraventricular small arteriovenous malformations: role of embolisation with cyanoacrylate. Neuroradiology 2005; 47:287-294.
17. Fleetwood IG, Marcellus ML, Levy RP, et al. Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg 2003; 98:747-750.
18. Khaw AV, Mohr JP, Sciacca RR, et al. Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke 2004; 35:660-663.
19. Maruyama K, Kondziolka D, Niranjan A, et al. Stereotactic radiosurgery for brainstem arteriovenous malformations: factors affecting outcome. J Neurosurg 2004; 100:407-413.
20. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005; 352:146-153.
21. Andrade-Souza YM, Zadeh G, Scora D, et al. Radiosurgery for basal ganglia, internal capsule, and thalamus arteriovenous malformation: clinical outcome. Neurosurgery 2005; 56:56-63; discussion 63-64.
22. Zipfel GJ, Bova FJ, Bradshaw P, et al. Do the morphological characteristics of arteriovenous malformations affect the results of radiosurgery? J Neurosurg 2004; 101:393-401.
23. Nataf F, Ghossoub M, Schlienger M, et al. Bleeding after radiosurgery for cerebral arteriovenous malformations. Neurosurgery 2004; 55:298-306. This study evaluated the severity of hemorrhage, the role of radiosurgery in the risk of hemorrhage, and the factors influencing the risk.
24. Friedman WA, Blatt DL, Bova FJ, et al. The risk of hemorrhage after radiosurgery for arteriovenous malformations. J Neurosurg 1996; 84:912-919.
25. Pollock BE, Flickinger JC, Lunsford LD, et al. Hemorrhage risk after stereotactic radio-surgery of cerebral arteriovenous malformations. Neurosurgery 1996; 38:652-659; discussion 659-661.
26. Herzig R, Burval S, Vladyka V, et al. Familial occurrence of cerebral arteriovenous malformation in sisters: case report and review of the literature. Eur J Neurol 2000; 7:95-100.
27. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002; 33:1190-1196; discussion 1190-1196.
28. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage [see Comments]. N Engl J Med 2000; 342:240-245.
29. Corral J, Iniesta JA, Gonzalez-Conejero R, et al. Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 2001; 97:2979-2982.
30. Alvarez-Sabin J, Delgado P, Abilleira S, et al. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 2004; 35:1316-1322.
31. Zhang B, Dhillon S, Geary I, et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 2001; 32:2198-2202.
32. Peters DG, Kassam AB, Feingold E, et al. Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 2001; 32:1036-1042.
33. Marchuk DA, Srinivasan S, Squire TL, et al. Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 2003; 12 (Suppl. 1):R97-R112.
34. Pawlikowska L, Tran MN, Achrol AS, et al. Polymorphisms in TGFB-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. Stroke 2005; in press.
35. Pawlikowska L, Tran MN, Achrol AS, et al. Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 2004; 35:2294-2300. This study first demonstrated the influence of genetic polymorphism on the ICH presentation of brain AVM, and suggested the role of inflammatory cytokines in the pathogenesis of brain AVM hemorrhage.
36. Chen Y, Shen F, Yao JS, et al. Interleukin-6 expression is increased in BAVM patients carrying a high-risk interleukin-6 gene polymorphism [Abstract]. J Neurosurg Anesthesiol 2004; 16:339, 340.
37. Minamisawa H, Nordstrom C-H, Smith M-L, et al. The influence of mild body and brain hypothermia on ischemic brain damage. J Cerebr Blood Flow Metab 1990; 10:365-374.
38. Clifton GL, Jiang JY, Lyeth BG, et al. Marked protection by moderate hypothermia after experimental traumatic brain injury. J Cerebr Blood Flow Metab 1991; 11:114-121.
39. Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336:540-546.
40. Krieger DW, De Georgia MA, Abou-Chebl A, et al. Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001; 32:1847-1854.
41. Todd MM, Hindman BJ, Clarke WR, et al. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005; 352:135-145. The IHAST was a multi-center, prospective, randomized trial that showed that intraoperative hypothermia did not improve the neurological outcome after craniotomy among good-grade patients with aneurysmal subarachnoid hemorrhage.
42. Steinberg GK, Ogilvy CS, Shuer LM, et al. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery 2004; 55:307-314; discussion 314-315.
43. Pile-Spellman J, Young WL, Joshi S, et al. Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: technical case report. Neurosurgery 1999; 44:881-886.
44. Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol 2005; 4:299-308. This recent review article voiced the need for studies on the risk-benefit ratios for the treatment of unruptured brain AVMs.
45. Hartmann A, Mast H, Mohr JP, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998; 29:931-934.
46. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 2003; 98:3-7.
47. Lee CZ, Xu B, Hashimoto T, et al. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke 2004; 35:1715-1719. This study demonstrated that tetracyclines could inhibit MMP-9 in the brain.
48. Hashimoto T, Matsumoto M, Li JF, et al. Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol 2005; 5:1.